Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark. / Pedersen, Sidsel Arnspang; Gaist, David; Schmidt, Sigrun Alba Johannesdottir; Holmich, Lisbet Rosenkrantz; Friis, Søren; Pottegard, Anton.

I: Journal of the American Academy of Dermatology, Bind 78, Nr. 4, e9, 2018, s. 673-681.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Pedersen, SA, Gaist, D, Schmidt, SAJ, Holmich, LR, Friis, S & Pottegard, A 2018, 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark', Journal of the American Academy of Dermatology, bind 78, nr. 4, e9, s. 673-681. https://doi.org/10.1016/j.jaad.2017.11.042

APA

Pedersen, S. A., Gaist, D., Schmidt, S. A. J., Holmich, L. R., Friis, S., & Pottegard, A. (2018). Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology, 78(4), 673-681. [e9]. https://doi.org/10.1016/j.jaad.2017.11.042

Vancouver

Pedersen SA, Gaist D, Schmidt SAJ, Holmich LR, Friis S, Pottegard A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. 2018;78(4):673-681. e9. https://doi.org/10.1016/j.jaad.2017.11.042

Author

Pedersen, Sidsel Arnspang ; Gaist, David ; Schmidt, Sigrun Alba Johannesdottir ; Holmich, Lisbet Rosenkrantz ; Friis, Søren ; Pottegard, Anton. / Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark. I: Journal of the American Academy of Dermatology. 2018 ; Bind 78, Nr. 4. s. 673-681.

Bibtex

@article{429b87aebdac451c950b97594977ec2b,
title = "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark",
keywords = "antihypertensives, cancer risk, hydrochlorothiazide, nonmelanoma skin cancer, pharmaco-epidemiology, pharmacology, skin cancer",
author = "Pedersen, {Sidsel Arnspang} and David Gaist and Schmidt, {Sigrun Alba Johannesdottir} and Holmich, {Lisbet Rosenkrantz} and S{\o}ren Friis and Anton Pottegard",
year = "2018",
doi = "10.1016/j.jaad.2017.11.042",
language = "English",
volume = "78",
pages = "673--681",
journal = "American Academy of Dermatology. Journal",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Hydrochlorothiazide use and risk of nonmelanoma skin cancer

T2 - A nationwide case-control study from Denmark

AU - Pedersen, Sidsel Arnspang

AU - Gaist, David

AU - Schmidt, Sigrun Alba Johannesdottir

AU - Holmich, Lisbet Rosenkrantz

AU - Friis, Søren

AU - Pottegard, Anton

PY - 2018

Y1 - 2018

KW - antihypertensives

KW - cancer risk

KW - hydrochlorothiazide

KW - nonmelanoma skin cancer

KW - pharmaco-epidemiology

KW - pharmacology

KW - skin cancer

U2 - 10.1016/j.jaad.2017.11.042

DO - 10.1016/j.jaad.2017.11.042

M3 - Journal article

C2 - 29217346

VL - 78

SP - 673

EP - 681

JO - American Academy of Dermatology. Journal

JF - American Academy of Dermatology. Journal

SN - 0190-9622

IS - 4

M1 - e9

ER -

ID: 209736960